Complete Filing Data
GUOCHUN INTERNATIONAL INC. reported Stockholders Equity of -$5.1 thousand for FY2022.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean GUOCHUN INTERNATIONAL INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Net Income * | -$26.6K | -$22.9K | -$16.6K | -$31.6K | -$24.0K | -$11.6K |
| Operating Expenses | $26.6K | $22.9K | $16.6K | $31.6K | $24.0K | $11.6K |
| Operating Income Loss | -$26.6K | -$22.9K | -$16.6K | $31.6K | $24.0K | -$11.6K |
| Other General And Administrative Expense | $21.00 | $236.00 | $1.5K | |||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$22.9K | -$16.6K | $31.6K | |||
| General And Administrative Expense | $1.5K | $2.4K | $2.4K | |||
| Comprehensive Income Net Of Tax | ||||||
| Revenues | $0.00 | $0.00 | ||||
| Income Loss From Continuing Operations | $31.6K | $24.0K | ||||
| Net Income Loss Available To Common Stockholders Basic | $16.6K | $31.6K | ||||
| Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest | -$22.9K | -$16.6K | ||||
| Amortization Of Intangible Assets | $1.3K | |||||
| Income Taxes Paid | $0.00 | $0.00 | ||||
| Income Loss From Discontinued Operations Net Of Tax | -$11.6K | |||||
| Deferred Income Tax Expense Benefit | $0.00 | |||||
| Income Tax Expense Benefit | ||||||
| Income Loss From Continuing Operations Before Income Taxes Domestic | ||||||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$25.3K | -$11.6K | -$894.00 | -$6.8K | -$5.6K | -$11.5K | -$6.2K | -$4.0K | -$7.4K | -$2.2K | -$3.7K | -$7.6K | -$2.7K | -$11.6K | -$5.6K | -$2.1K | -$13.3K | -$7.0K | -$2.4K | -$2.0K | -$5.6K |
| Operating Expenses | $25.3K | $11.6K | $894.00 | $6.8K | $5.6K | $11.5K | $6.2K | $4.0K | $7.4K | $2.2K | $3.7K | $7.6K | $2.7K | $11.6K | $5.6K | $2.1K | $13.3K | $7.0K | $2.4K | $2.0K | $5.6K |
| Operating Income Loss | -$25.3K | -$11.6K | -$894.00 | -$6.8K | -$5.6K | -$11.5K | -$6.2K | $4.0K | -$7.4K | $2.2K | $3.7K | $7.6K | $2.7K | -$11.6K | $5.6K | -$2.1K | -$13.3K | -$7.0K | -$2.4K | -$2.0K | |
| Other General And Administrative Expense | $13.5K | $2.1K | $894.00 | $1.0K | $1.6K | $1.5K | $1.4K | $2.5K | $21.00 | $66.00 | $1.3K | $2.1K | $746.00 | $285.00 | |||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$25.3K | -$11.6K | -$894.00 | -$6.8K | -$5.6K | -$11.5K | -$6.2K | -$4.0K | $7.4K | -$2.2K | $3.7K | -$7.6K | $11.6K | ||||||||
| General And Administrative Expense | $2.1K | $746.00 | $285.00 | $227.00 | $2.1K | $596.00 | $7.0K | $2.4K | $2.0K | $5.6K | |||||||||||
| Comprehensive Income Net Of Tax | -$25.3K | -$11.6K | -$894.00 | -$6.8K | -$5.6K | -$11.5K | -$6.2K | -$4.0K | $2.2K | $3.7K | |||||||||||
| Revenues | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Income Loss From Continuing Operations | -$11.5K | -$7.4K | $2.2K | $7.6K | $2.7K | -$11.6K | $5.6K | -$2.1K | -$13.3K | ||||||||||||
| Net Income Loss Available To Common Stockholders Basic | -$6.8K | -$5.6K | -$11.5K | -$6.2K | -$4.0K | -$7.4K | -$2.2K | -$3.7K | -$7.6K | -$11.6K | |||||||||||
| Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest | -$6.2K | $4.0K | -$2.2K | $3.7K | |||||||||||||||||
| Amortization Of Intangible Assets | $1.1K | $157.00 | |||||||||||||||||||
| Income Taxes Paid | |||||||||||||||||||||
| Income Loss From Discontinued Operations Net Of Tax | -$7.0K | -$2.0K | -$5.6K | ||||||||||||||||||
| Deferred Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | ||||||||||||||||||
| Income Tax Expense Benefit | $3.7K | $11.6K | |||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Domestic | $2.2K | $2.7K | |||||||||||||||||||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $2.2K | $2.7K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|
| Stockholders Equity * | -$5.1K | -$44.3K | -$12.6K | -$10.4K | ||
| Common Stock Value | $3.9K | $3.9K | $3.9K | $3.9K | $0.00 | $0.00 |
| Liabilities Current | $28.0K | $5.1K | $45.3K | $14.1K | $10.6K | $2.1K |
| Retained Earnings Accumulated Deficit | -$108.5K | -$85.6K | $69.0K | -$37.4K | -$13.4K | -$1.8K |
| Liabilities | $28.0K | $5.1K | $45.3K | $14.1K | -$10.4K | $3.2K |
| Assets Current | $1.1K | $1.4K | $196.00 | $3.2K | ||
| Assets | $1.1K | $1.4K | $196.00 | $3.2K | ||
| Liabilities And Stockholders Equity | $1.1K | $1.4K | $196.00 | $1.2K | ||
| Accounts Payable And Accrued Liabilities Current | $994.00 | $1.7K | $100.00 | |||
| Cash And Cash Equivalents At Carrying Value | $1.1K | $70.00 | $100.00 | |||
| Accounts Payable Current | $5.0K | $1.5K | $304.00 | |||
| Cash | $1.1K | $70.00 | $100.00 | |||
| Liabilities Noncurrent | $10.6K | $2.1K | ||||
| Interest Payable Current | $9.1K | $1.8K | ||||
| Cash Cash Equivalents And Short Term Investments | $100.00 | |||||
| Cash Period Increase Decrease | $1.4K | -$30.00 | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.1K | $1.4K | ||||
| Receivable From Officers And Directors For Issuance Of Capital Stock | $3.0K | |||||
| Debt Current | $27.0K | |||||
| Loans And Leases Receivable Related Parties Proceeds | $9.3K | $36.2K | $0.00 | $7.3K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $1.1K | $357.00 | ||||
| Margin Deposit Assets | $126.00 | |||||
| Deposit Assets | $0.00 | $126.00 | ||||
| Cash And Cash Equivalents Fair Value Disclosure | $1.1K | $1.4K | ||||
| Accrued Liabilities Current | $45.2K | |||||
| Investments In And Advances To Affiliates At Fair Value Period Increase Decrease | $3.4K | |||||
| Cash Period Increase Decrease Excluding Exchange Rate Effect | -$357.00 | $1.4K | ||||
| Common Stock Value Outstanding | $3.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$92.5K | -$67.1K | -$55.5K | -$54.6K | -$52.0K | -$45.1K | -$39.5K | -$28.0K | -$22.6K | -$16.4K | -$12.4K | -$5.1K | -$1.9K | -$269.00 | -$51.9K | -$44.3K | -$32.4K | -$29.8K | -$18.2K | -$12.6K | -$11.0K | -$8.9K | -$886.00 | -$8.9K | -$6.5K | -$4.4K | $1.2K | ||
| Common Stock Value | $3.9K | $3.9K | $3.9K | $3.9K | $3.9K | $3.9K | $3.9K | $3.9K | $3.9K | $3.9K | $3.9K | $3.9K | $3.9K | $3.9K | $3.9K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.0K | ||||||
| Liabilities Current | $92.5K | $67.1K | $55.5K | $54.6K | $52.0K | $45.1K | $39.5K | $22.6K | $16.4K | $12.4K | $1.9K | $1.3K | $74.0K | $32.8K | $30.3K | $24.4K | $14.1K | $15.6K | $11.7K | $9.7K | $7.5K | $4.7K | |||||||
| Retained Earnings Accumulated Deficit | -$173.0K | -$147.6K | -$136.0K | -$135.1K | -$132.5K | -$125.6K | -$120.0K | $97.0K | $93.0K | $82.5K | $80.3K | -$76.6K | -$57.2K | -$54.5K | -$42.9K | -$35.7K | -$33.7K | -$20.4K | -$11.9K | -$9.5K | -$7.4K | ||||||||
| Liabilities | $92.5K | $67.1K | $55.5K | $54.6K | $74.0K | $32.8K | $30.3K | -$18.2K | -$11.0K | -$8.9K | -$886.00 | -$8.9K | -$6.5K | $284.00 | |||||||||||||||
| Assets Current | $1.0K | $304.00 | $409.00 | $505.00 | $6.2K | $3.1K | $6.7K | $10.8K | $822.00 | $976.00 | $284.00 | ||||||||||||||||||
| Assets | $1.0K | $22.1K | $409.00 | $505.00 | $6.2K | $3.1K | $6.7K | $10.8K | $822.00 | $976.00 | $284.00 | ||||||||||||||||||
| Liabilities And Stockholders Equity | $1.0K | $22.1K | $409.00 | $505.00 | $6.2K | $3.1K | $6.7K | $10.8K | $822.00 | $976.00 | |||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | $46.4K | $21.1K | $10.0K | $9.1K | $6.4K | $596.00 | $8.0K | $1.3K | $298.00 | $3.1K | $297.00 | $1.3K | |||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $1.0K | $409.00 | $505.00 | $6.2K | $1.4K | $2.9K | $6.6K | $10.7K | $696.00 | $696.00 | $158.00 | ||||||||||||||||||
| Accounts Payable Current | $5.0K | $100.00 | $447.00 | $5.0K | $5.0K | $6.6K | $2.6K | $2.7K | $1.4K | $3.0K | |||||||||||||||||||
| Cash | $1.0K | $409.00 | $505.00 | $6.2K | $1.4K | $2.9K | $6.6K | $10.7K | $70.00 | $696.00 | $696.00 | $158.00 | |||||||||||||||||
| Liabilities Noncurrent | $24.4K | $14.1K | $14.1K | $15.6K | $11.7K | $9.7K | $7.5K | $4.7K | |||||||||||||||||||||
| Interest Payable Current | $19.4K | $9.1K | $9.1K | $9.1K | $9.1K | $7.0K | $6.1K | $1.8K | |||||||||||||||||||||
| Cash Cash Equivalents And Short Term Investments | $1.4K | $70.00 | $696.00 | $696.00 | |||||||||||||||||||||||||
| Cash Period Increase Decrease | $4.7K | $10.6K | $58.00 | ||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.0K | $304.00 | $409.00 | $505.00 | |||||||||||||||||||||||||
| Receivable From Officers And Directors For Issuance Of Capital Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||
| Debt Current | $46.0K | $46.0K | $45.5K | $45.5K | $45.5K | $44.5K | |||||||||||||||||||||||
| Loans And Leases Receivable Related Parties Proceeds | $1.8K | ||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$771.00 | ||||||||||||||||||||||||||||
| Margin Deposit Assets | $126.00 | $126.00 | $126.00 | $126.00 | |||||||||||||||||||||||||
| Deposit Assets | $126.00 | $126.00 | $126.00 | $126.00 | |||||||||||||||||||||||||
| Cash And Cash Equivalents Fair Value Disclosure | $304.00 | $409.00 | $505.00 | $6.2K | $2.9K | $6.6K | |||||||||||||||||||||||
| Accrued Liabilities Current | $21.3K | $16.1K | $9.4K | $3.4K | |||||||||||||||||||||||||
| Investments In And Advances To Affiliates At Fair Value Period Increase Decrease | $6.0K | ||||||||||||||||||||||||||||
| Cash Period Increase Decrease Excluding Exchange Rate Effect | |||||||||||||||||||||||||||||
| Common Stock Value Outstanding | $3.9M | $3.9M | $3.9M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$18.5K | -$23.7K | -$13.7K | $36.5K | $20.4K | -$10.3K |
| Net Cash Provided By Used In Financing Activities | $18.5K | $23.7K | $12.7K | $36.2K | $21.7K | $10.3K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $8.1K | -$728.00 | $1.6K | $4.9K | $3.5K | $1.2K |
| Proceeds From Collection Of Loans Receivable | $0.00 | $3.0K | ||||
| Proceeds From Related Party Debt | $3.4K | $36.2K | ||||
| Payments For Repurchase Of Common Stock | $21.7K | $0.00 | ||||
| Proceeds From Payments For Other Financing Activities | $18.5K | $23.7K | ||||
| Increase Decrease In Accounts Payable | $4.9K | -$3.5K | ||||
| Payments To Fund Longterm Loans To Related Parties | $7.3K | |||||
| Proceeds From Issuance Or Sale Of Equity | $21.7K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q2 2022 | Q1 2022 | Q1 2021 | Q2 2020 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$4.5K | $6.0K | $2.6K | $5.6K | -$5.9K | -$2.9K | |||
| Net Cash Provided By Used In Financing Activities | $4.5K | $6.0K | $1.8K | $10.3K | $16.5K | $3.0K | |||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $894.00 | -$7.0K | $1.4K | $4.9K | $0.00 | $1.1K | $2.7K | ||
| Proceeds From Collection Of Loans Receivable | $0.00 | $3.0K | |||||||
| Proceeds From Related Party Debt | $4.5K | $6.0K | $1.8K | $10.3K | |||||
| Payments For Repurchase Of Common Stock | $76.1K | $0.00 | $16.5K | $0.00 | |||||
| Proceeds From Payments For Other Financing Activities | $4.5K | ||||||||
| Increase Decrease In Accounts Payable | $4.9K | ||||||||
| Payments To Fund Longterm Loans To Related Parties | $0.00 | $0.00 | |||||||
| Proceeds From Issuance Or Sale Of Equity | $5.2K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.01 | -$0.01 | $0.00 | ||||
| Common Stock Shares Outstanding | 3.9M | 3.9M | 3.9M | 3.0M | |||
| Shares Outstanding | 3.9M | 3.9M | 3.9M | ||||
| Common Stock Shares Issued | 3.9M | 3.9M | 3.9M | 3.0K | 3.0K | ||
| Common Stock Shares Authorized | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | ||
| Weighted Average Number Of Shares Outstanding Basic | 3.9M | 3.9M | 3.9M | 3.9M | |||
| Earnings Per Share Basic | $-0.01 | $-0.01 | $0.00 | $-0.01 | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 3.7M | 3.0M | |||||
| Shares Issued | |||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 3.9M | 3.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||
| Common Stock Shares Outstanding | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.7M | 3.0M | 3.0M | 3.0M | 3.0M | ||||||
| Shares Outstanding | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | |||||||||||||
| Common Stock Shares Issued | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9K | 3.9K | 3.9K | 3.9K | 3.7K | 3.0K | 3.0K | 3.0K | |||||||
| Common Stock Shares Authorized | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | |||||||
| Weighted Average Number Of Shares Outstanding Basic | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | ||||||||||||||
| Earnings Per Share Basic | $-0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.8M | 3.2M | 3.0M | 3.0M | 3.0M | |||||||||||||||||
| Shares Issued | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M | 3.9K | |||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 3.9M | 3.9M | 3.9M | 3.8M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Professional Fees | $26.6K | $22.9K | $15.1K | $30.1K | $21.6K | |
| Additional Paid In Capital | $76.6K | $76.6K | $20.9K | $20.9K | $0.00 | |
| Current State And Local Tax Expense Benefit | $0.00 | $0.00 | ||||
| Interest Paid | $0.00 | $0.00 | ||||
| Loss Contingency Loss In Period | -$24.0K | -$11.6K | ||||
| Advances Fair Value Disclosure | $9.1K | |||||
| Capitalized Computer Software Period Increase Decrease | $22.0K | |||||
| Stock Issued During Period Shares New Issues | 870.6K | |||||
| Depreciation And Amortization | $1.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Professional Fees | $11.8K | $9.5K | $5.8K | $4.0K | $10.0K | $4.8K | $1.5K | $7.3K | $2.1K | $1.3K | $5.3K | $1.9K | $11.3K | $5.3K | $12.7K | $6.4K | |||||||
| Additional Paid In Capital | $76.6K | $76.6K | $76.6K | $76.6K | $76.6K | $76.6K | $76.6K | $76.6K | $76.6K | $76.6K | $76.2K | $20.9K | $20.9K | $20.9K | $20.9K | $20.9K | $20.9K | $15.9K | |||||
| Current State And Local Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||
| Interest Paid | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||
| Loss Contingency Loss In Period | -$7.0K | -$5.6K | |||||||||||||||||||||
| Advances Fair Value Disclosure | $69.0K | $45.2K | $32.4K | $30.3K | |||||||||||||||||||
| Capitalized Computer Software Period Increase Decrease | $22.0K | ||||||||||||||||||||||
| Stock Issued During Period Shares New Issues | |||||||||||||||||||||||
| Depreciation And Amortization | $157.00 |
Most recent annual filing with the SEC: July 22, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.